Verratti Mark

Verratti Mark is listed in filings as Chief Operating Officer at Myriad Genetics, Inc.. This profile follows SEC Form 4 activity through Apr 15, 2026, including 22 public disclosures. Recent filings connect the profile to Myriad Genetics, Inc. (MYGN). The current snapshot covers public activity from Sep 23, 2024 to Apr 15, 2026. Reported amounts are shown as $5.2K to $42.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.